Jaguar Health, Inc. JAGX

Rank #2522 · Nasdaq · $0.3B market cap

⚠ Going-concern flag — the auditor (RBSM LLP) raised substantial doubt about this company's ability to continue operating in the latest filing. Read the actual filing before drawing conclusions.

Score

8.1

P/E

-7.2

P/B

56.69

ROE

-786.0%

Op. Margin

-263.8%

Debt Ratio

908%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆

Poor

P/E -7.2x, P/B 56.69x. Ranks in the top 90% of the universe.

Profitability ★☆☆☆☆

Poor

ROE -786.0%. Ranks in the top 96% of the universe.

Safety ★☆☆☆☆

Poor

Debt ratio 908%. Ranks in the top 89% of the universe. Above 200% signals meaningful leverage risk.

Growth ★★★★☆

Excellent

Revenue growth of 19.8% year over year. Ranks in the top 19% of the universe.

Growth is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2015	$0.0B	$-0.0B	$-0.0B	$-0.0B	–	-1230
2016	$0.0B	$-0.0B	$-0.0B	$-0.0B	-4816.7	-97
2017	$0.0B	$-0.0B	$-0.0B	$0.0B	-9599.8	137
2018	$0.0B	$-0.0B	$-0.0B	$-0.0B	-785.3	-1074
2019	$0.0B	$-0.0B	$-0.0B	$0.0B	-698.0	154
2020	$0.0B	$-0.0B	$-0.0B	$0.0B	-501.3	294
2021	–	$-0.0B	$-0.0B	$0.0B	–	240
2022	$0.0B	$-0.0B	$-0.1B	$0.0B	-939.1	241
2023	–	$-0.0B	$-0.0B	$0.0B	–	412
2024	$0.0B	$-0.0B	$-0.0B	$-0.0B	-351.3	-3375
2025	$0.0B	$-0.0B	$-0.0B	$0.0B	-263.8	908

← See the full screener